Sign In

Collin Horner

Co-founder & Chief Business Officer at Cura Therapeutics

Collin Horner is the Co-Founder and Chief Business Officer of Cura Therapeutics Inc., a biotech company focused on developing innovative immunotherapies for cancer and infectious diseases.12 With over 20 years of experience in business development, marketing, and communication, Horner brings valuable expertise to the company.13

Professional Background

Throughout his career, Horner has worked on various projects across different industries, including:

  • Healthcare
  • Real estate development
  • Product branding

He has successfully launched numerous marketing and advertising campaigns for both global brands and early-stage startups.1

Role at Cura Therapeutics

At Cura Therapeutics, Horner's primary responsibilities include:

  • Leading business development efforts
  • Focusing on building strategic partnerships
  • Securing funding to advance the company's technology towards clinical trials1

Currently, Horner is actively involved in raising the company's first seed round and series A funding.1

Company Overview

Cura Therapeutics, co-founded by Horner and Dr. Claudia A. Penafuerte Diaz, is developing a novel immunotherapy platform to treat solid malignancies. Their proprietary technology combines:

  1. Reactivation of the immune system's response against cancer
  2. Disruption of the tumor's blood supply

This unique approach sets Cura Therapeutics apart in the immuno-oncology market, as there are currently no treatments that combine these properties in a single therapeutic.2

Horner's expertise in business development and marketing, combined with Dr. Penafuerte Diaz's scientific background, forms a strong foundation for the company's growth and potential success in the biotech industry.

Related Questions

What are some of the key projects Collin Horner has worked on in his 20-year career?
How did Collin Horner transition from marketing and communication to business development in the healthcare sector?
What specific challenges has Collin Horner faced in raising seed and series A funding for Cura Therapeutics?
How does Cura Therapeutics' immunotherapy platform differ from other immunotherapies on the market?
What role does Claudia Penafuerte Diaz play in the development of Cura Therapeutics' technology?
Collin Horner
Collin Horner, photo 1
Collin Horner, photo 2
Add to my network

Location

Montreal, Quebec, Canada